Literature DB >> 12742447

Cancellous and cortical morselized allograft in revision total hip replacement: A biomechanical study of implant stability.

Mordechai Kligman1, Assa Rotem, Moshe Roffman.   

Abstract

To restore femoral intramedullary bone stock loss in revision surgery of failed total hip arthroplasties, impacted morselized cancellous allograft is recommended. This study investigated the mechanical properties of both impacted cortical (group A) and cancellous (group B) morselized bone graft for reconstruction of femoral bones. Ten matched pairs of fresh frozen human femora were prepared by over-reaming to create a smooth-walled cortical shell. Each pair had one cortical and one cancellous impacted morselized allograft and cement. Stem subsidence was evaluated by a cyclic axial load, which was applied by a servohydraulic test. The stem subsidence was measured for initial subsidence (subsidence at the first 1000 cycles), the total axial subsidence (subsidence at the end of cycles under load) and the final axial subsidence (subsidence after the unloading phase). Torque test was measured by torsional loads through the prosthetic femoral heads. Total axial subsidence was significantly higher in group B (mean: 1.32+/-0.32 mm) compared to group A (mean: 0.94+/-0.26 mm) (P<0.01). There was no significant difference between the two groups in terms of initial subsidence (P=0.09) and final axial subsidence. The mean maximum torque before failure was 39.5+/-22.2 N-m for the cortical morselized allograft and 32.5+/-18.1N-m for cancellous. We concluded that impacted morselized cortical bone graft used for reconstruction of contained femoral bone loss in revision hip arthroplasty, may reduce the stem subsidence. Further animal experimentation for mechanical and histological evaluation of in vivo application is warranted.

Entities:  

Mesh:

Year:  2003        PMID: 12742447     DOI: 10.1016/s0021-9290(03)00013-7

Source DB:  PubMed          Journal:  J Biomech        ISSN: 0021-9290            Impact factor:   2.712


  7 in total

1.  The locking attachment plate for proximal fixation of periprosthetic femur fractures--a biomechanical comparison of two techniques.

Authors:  Mark Lenz; Markus Windolf; Thomas Mückley; Gunther O Hofmann; Michael Wagner; Robert G Richards; Karsten Schwieger; Boyko Gueorguiev
Journal:  Int Orthop       Date:  2012-05-27       Impact factor: 3.075

Review 2.  [Influence of thermodisinfection on impaction of cancellous bone : An in vitro model of femoral impaction bone grafting].

Authors:  C Fölsch; A Jahnke; A Groß; G Martels; G A Krombach; M Rickert; M Kampschulte
Journal:  Orthopade       Date:  2018-01       Impact factor: 1.087

Review 3.  [Allogeneic bone transplantation in hip revision surgery : Indications and potential for reconstruction].

Authors:  G A Ahmed; B Ishaque; M Rickert; C Fölsch
Journal:  Orthopade       Date:  2018-01       Impact factor: 1.087

4.  Influence of antibiotic pellets on pore size and shear stress resistance of impacted native and thermodisinfected cancellous bone: An in vitro femoral impaction bone grafting model.

Authors:  C Fölsch; J Bok; G A Krombach; M Rickert; C A Fonseca Ulloa; G A Ahmed; M Kampschulte; A Jahnke
Journal:  J Orthop       Date:  2020-09-19

5.  The threshold force required for femoral impaction grafting in revision hip surgery.

Authors:  Olivia M Flannery; John R Britton; Peter O'Reilly; Nicholas Mahony; Patrick J Prendergast; Paddy J Kenny
Journal:  Acta Orthop       Date:  2010-06       Impact factor: 3.717

6.  Medium- to Long-term Results of Strut Allografts Treating Periprosthetic Bone Defects.

Authors:  Jun Sung Park; Kyoung Ho Moon
Journal:  Hip Pelvis       Date:  2018-03-05

7.  Effect of synthetic bone replacement material of different size on shear stress resistance within impacted native and thermodisinfected cancellous bone: an in vitro femoral impaction bone grafting model.

Authors:  C Fölsch; P Sahm; C A Fonseca Ulloa; G A Krombach; M Kampschulte; M Rickert; A Pruss; A Jahnke
Journal:  Cell Tissue Bank       Date:  2021-04-24       Impact factor: 1.522

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.